Calendar

Allstate had a reported positive EPS revision trend and prior-quarter underwriting strength, but the checked sources disagreed materially on Q3 consensus values and did not establish a positive revenue revision. Recent shares were down, closes were weak within their daily ranges, and volume did not show accumulation; the modest estimate signal is insufficient for a pre-event surprise setup.

MetLife had constructive Q3 EPS estimate revisions and solid Q2 operating momentum, with consensus revenue growth also forecast. The stock had weakened over the latest five sessions, lacked a qualifying close location or volume surge, and no upward revenue revision or specific revenue surprise signal was verified; the setup is therefore incomplete.

Aflac’s stock has risen over the past month and had a qualifying close location on Oct 27, but the checked sources show a slight prior-quarter EPS miss and supply consensus rather than positive estimate revisions or a revenue-upside signal; recent volume also does not qualify.

Edwards reported Q2 sales growth and raised full-year sales guidance, and the October 28 close was in the upper portion of its daily range. However, sources checked for the November 4 date describe it as estimated, not company-confirmed; moreover, no positive current EPS/revenue estimate revision or unusual volume was verified.

The company confirmed a Nov 4 after-close Q3 release, and available sources show EPS and revenue consensus estimates. However, no positive estimate revisions or revenue upside evidence was found; VMRK fell 1.6% over five sessions, underperformed the S&P 500, and Oct 28 volume was below normal. Merger integration is a disclosed risk, so this is not a qualifying surprise setup.

COHR's October 26-28 rebound lifted the close to $239.59, with a strong October 27 close location, and its prior company guidance described substantial growth and margin expansion. However, verified pre-event positive estimate revisions/revenue upside and a recent 1.5x volume session are absent; the tape also includes a sharp October 22 decline. It remains a non-qualifying partial setup.

The prior quarter showed strong commerce, fintech, and advertising growth, but the available pre-event estimate report says consensus EPS was revised 0.62% lower over 30 days, and I found no supported positive revenue revision or usable dated price/volume and sector tape. The Nov. 4 date is estimated by the independent calendar sources rather than confirmed there; insufficient signal for inclusion.

MBWM closed October 20 at $59.04, up 1.06% from $58.42 before the release; that modest positive reaction does not establish durable repricing. One reported target increase is available, but broader post-print estimate revisions are not. The stored earnings-document row concerns Old National Bancorp, not MBWM, and was excluded. Social, options, short-interest and employee measures were not evidenced; the zero fields above indicate unavailable data, not neutral readings. [Price history](https://stockanalysis.com/stocks/mbwm/history/) [Target-change report](https://www.tipranks.com/news/the-fly/mercantile-bank-price-target-raised-to-65-from-64-at-keefe-bruyette-thefly-news)

The October 20 close rose 4.47% from $19.92 to $20.81 after the release, so part of the EPS beat and improved outlook appears reflected in price. News tone is positive but not unqualified: revenue was slightly below FactSet consensus. No verified post-print analyst target changes or forward-estimate revisions were found at T+1; the zero-valued social, options, short-interest and employee fields indicate unavailable evidence, not neutral readings. [price history](https://stockanalysis.com/stocks/key/history/) [consensus comparison](https://finance.yahoo.com/markets/stocks/articles/keycorp-apos-q3-adjusted-earnings-104120252.html)

The company release supports a modestly better operating view, consistent with the packet's positive directional prior, but credit and underlying deposit trends temper the thesis change. Zacks reported the EPS beat; a market tracker shows an approximately +0.5% next-day move, not a decisive repricing. Post-print analyst revisions and reliable social, options, short-interest and employee signals were unavailable; zero values above denote unavailable data, not measured neutrality. The scheduled T+1 trigger names October 20, but the company filed its Q3 release on October 15.

This T+1 update replaces the April monitoring baseline with a mixed Q3 print. Adjusted EPS was roughly in line with one cited consensus, while GAAP EPS included a disclosed acquisition charge; calling the result an unqualified $0.30 operating miss would be misleading. [Zacks estimate comparison](https://www.zacks.com/stock/news/3011517/hancock-whitney-hwc-q3-earnings-taking-a-look-at-key-metrics-versus-estimates) [#SEC-8K-2026-10-20] [SEC earnings release](https://www.sec.gov/Archives/edgar/data/750577/000119312526426654/hwc-ex99_1.htm) One report placed shares at $73.25 after hours, about 1.2% below the $74.13 close; a sustained next-session reaction is not yet verified. [Investing.com reaction](https://in.investing.com/news/stock-market-news/earnings-call-transcript-hancock-whitney-misses-q3-2026-eps-forecast-93CH-5643830) Post-print analyst revisions remain unavailable. The deterministic delta prior is negative, so stronger adjusted profit does not yet justify upgrading this cautious monitoring view. Social, options, short-interest, and employee measures were not supplied; numeric placeholders in the sentiment object should not be interpreted as observed readings.

The Q3 print improved the evidence-backed outlook, but this T+1 view remains measured. HAL closed October 20 at $33.59, up 1.85% on the day, a smaller gain than some early premarket reports suggested. [Price history](https://stockanalysis.com/stocks/hal/history/) One reported post-print target increase is available, but a broader analyst-revision or forward-estimate trend is not yet established. No sufficient social, options, short-interest, or employee-sentiment data were supplied; zero entries in those fields denote unavailable data, not neutral readings.

The October 20 anchor price is not a verified post-earnings reaction. No Q3 release, surprise versus consensus, guidance revision, analyst target change or attributable market reaction was available by the research cutoff. Q2 company evidence remains constructive, but the scheduled earnings trigger alone does not change the neutral thesis [#SEC-8K-2026-07-22]. Zero-valued sentiment fields mean unavailable measurements, not observed neutral readings.

Are food recalls increasing under RFK ? What the data reveals .